Abstract
Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 126-129 |
| Number of pages | 4 |
| Journal | Current Opinion in Biotechnology |
| Volume | 11 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2000 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Biotechnology
Cite this
Plants for delivery of edible vaccines. / Walmsley, Amanda M.; Arntzen, Charles J.
In: Current Opinion in Biotechnology, Vol. 11, No. 2, 01.04.2000, p. 126-129.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Plants for delivery of edible vaccines
AU - Walmsley, Amanda M.
AU - Arntzen, Charles J.
PY - 2000/4/1
Y1 - 2000/4/1
N2 - Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.
AB - Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.
UR - http://www.scopus.com/inward/record.url?scp=0034026208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034026208&partnerID=8YFLogxK
U2 - 10.1016/S0958-1669(00)00070-7
DO - 10.1016/S0958-1669(00)00070-7
M3 - Article
C2 - 10753769
AN - SCOPUS:0034026208
VL - 11
SP - 126
EP - 129
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
SN - 0958-1669
IS - 2
ER -